Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Tislelizumab-jsgr

HealthData.Gov

Updated Mar 24, 2026

About this dataset

TEVIMBRA (tislelizumab-jsgr) is an intravenous injection used as an immunotherapy drug that blocks programmed death receptor-1 (PD-1) to help the immune system fight certain cancers. Manufactured by BeOne Medicines USA, Inc., it's available as a 10 mg/mL solution concentrate, approved under BLA761232 and marketed since March 2024. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Tislelizumab-jsgr

    Access the FDA dataset for Tislelizumab-jsgr β€” ANDA 203308 submitted by Mylan Institutional LLC

    Modified Dec 27, 2025

Prototype by Datopian Β· not an official government website Β· data from data.virginia.gov